Welcome to this special series of the Moneyball Medicine Podcast focused on Artificial Intelligence, Machine Learning and Analytics applied to Drug Discovery and Development. This special series was recorded as part of the AI Applications Summit produced by Corey Lane Partners this October (2018) in Boston, MA. In this series I have interviewed different speakers from the event and we will hear their experiences. We will dive into the challenges and opportunities they’re facing, and their predictions for the years to come.
This is part 5 of a special 6-part series. Harry’s guest is Guido Lanza, president and CEO of Numerate. They tackle the question: What if the introduction of Artificial Intelligence into drug discovery allowed us to create a true learning loop?